AYTU BIOPHARMA, INC Cash
AYTU BIOPHARMA, INC (AYTU) had Cash of $12.10 million as of 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2018-05-14
- 2018-03-31: Cash $12.10M.
- 2017-12-31: Cash $4.00M.
- 2015-02-28: Cash $100.00.
- 2014-11-30: Cash $9.00K.
| Period end | Cash |
|---|---|
| 2018-03-31 | $12.10M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $4.00M 10-Q · filed 2018-02-08 |
| 2015-02-28 | $100.00 10-Q · filed 2015-04-15 |
| 2014-11-30 | $9.00K 10-Q · filed 2015-01-12 |
| 2014-08-31 | $2.31K 10-Q · filed 2015-04-15 |
| 2014-05-31 | $8.97K 10-Q · filed 2014-07-10 |
| 2014-02-28 | $184.00 10-Q · filed 2015-04-15 |
| 2013-11-30 | $445.00 10-Q · filed 2015-01-12 |
| 2013-08-31 | $1.86K 10-Q · filed 2015-04-15 |
| 2013-05-31 | $728.00 10-Q · filed 2014-07-10 |
| 2013-02-28 | $3.19K 10-Q · filed 2014-04-11 |
| 2012-11-30 | $701.00 10-Q · filed 2014-01-10 |
| 2012-08-31 | $109.00 10-K · filed 2014-11-26 |
| 2012-05-31 | $48.00 10-Q · filed 2013-06-28 |
| 2012-02-29 | $848.00 10-Q · filed 2013-04-15 |
| 2011-11-30 | $1.72K 10-Q · filed 2013-01-14 |
| 2011-08-31 | $3.99K 10-K · filed 2014-11-26 |
| 2011-05-31 | $7.01K 10-Q · filed 2012-06-26 |
| 2011-02-28 | $6.27K 10-Q · filed 2012-04-12 |
| 2010-11-30 | $911.00 10-Q · filed 2011-12-23 |
| 2010-08-31 | $1.54K 10-K · filed 2012-11-29 |
| 2005-02-28 | $100.00 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |